An Expert's Perspective on the Need to Manage Folate When Treating Depression
-
An expert's perspective
Dr Andrew Cutler demonstrates how the STAR*D study reveals the need for better outcomes from initial MDD treatment based on the incidence of treatment failure and subsequent remission rates in patients who initiate treatment with a single-agent antidepressant.
-
Discover the role of folate in depression
Watch Dr Andrew Cutler, Chief Medical Officer of Meridien Research in Bradenton, Florida, describe the role of active folate and how DEPLIN® works.
-
Discover the role of DEPLIN® on neurotransmitters in depression
Watch Dr Andrew Cutler, Chief Medical Officer of Meridien Research in Bradenton, Florida discuss the respective roles of neurotransmitters and SSRIs in MDD; and how DEPLIN® works.
Is DEPLIN® Safe and Well Tolerated
Have confidence knowing DEPLIN® can be safely
added to patients’ current therapy.
Savings, support, and resources
for patients taking DEPLIN®
Help Patients Save on DEPLIN®